Press Releases

Notice of Results Update

Full Year Results to be Published on 6th May 2020   Oxford, UK – 16th April, 2020: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), a leading gene and…

Read more

Building the Group for future growth

Business Update Oxford, UK – 18 March 2020: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), a leading gene and cell therapy group, announces today an unaudited trading and…

Read more